Comparison between Classic Electrodes IPO and Curis Lifesciences IPO.
Classic Electrodes IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Curis Lifesciences IPO is a SME Bookbuilding proposed to list at NSE SME.
| Classic Electrodes IPO | Curis Lifesciences IPO | |
|---|---|---|
| Logo | ![]() | ![]() |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | GYR Capital Advisors Pvt.Ltd. | Finaax Capital Advisors Private Limited |
| Registrar | MUFG Intime India Pvt.Ltd. | MUFG Intime India Pvt.Ltd. |
| Market Maker | Wiinance Financial Services Pvt.Ltd. | RS Wealth Management Private Limited |
| DRHP | DRHP ![]() | DRHP ![]() |
| RHP | RHP ![]() | RHP ![]() |
| Final Prospectus | Final Prospectus ![]() | Final Prospectus ![]() |
| Anchor Investor | Anchor Investor ![]() | Anchor Investor ![]() |
| IPO Allotment URL | IPO Allotment URL ![]() | IPO Allotment URL ![]() |
The total issue size of Classic Electrodes IPO is up to ₹39.09 Cr whereas the issue size of the Curis Lifesciences IPO is up to ₹26.14 Cr. The final issue price of Classic Electrodes IPO is ₹87.00 per share and of Curis Lifesciences IPO is ₹128.00 per share.
| Classic Electrodes IPO | Curis Lifesciences IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹82.00 per share | ₹120.00 per share |
| Issue Price (Upper) | ₹87.00 per share | ₹128.00 per share |
| Issue Price (Final) | ₹87.00 per share | ₹128.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 1000 shares |
| Fresh Issue Size | 44,92,800 shares | 20,42,000 shares |
| Fresh Issue Size (Amount) | up to ₹39.09 Cr | up to ₹26.14 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 44,92,800 shares | 20,42,000 shares |
| Issue Size Total (Amount) | up to ₹39.09 Cr | up to ₹26.14 Cr |
Classic Electrodes IPO opens on Aug 22, 2025, while Curis Lifesciences IPO opens on Nov 07, 2025. The closing date of Classic Electrodes IPO and Curis Lifesciences IPO is Aug 26, 2025, and Nov 11, 2025, respectively.
| Classic Electrodes IPO | Curis Lifesciences IPO | |
|---|---|---|
| Anchor Bid Date | Aug 21, 2025 | Nov 06, 2025 |
| Issue Open | Aug 22, 2025 | Nov 07, 2025 |
| Issue Close | Aug 26, 2025 | Nov 11, 2025 |
| Basis Of Allotment (Tentative) | Aug 28, 2025 | Nov 12, 2025 |
| Initiation of Refunds (Tentative) | Aug 28, 2025 | Nov 13, 2025 |
| Credit of Share (Tentative) | Aug 29, 2025 | Nov 13, 2025 |
| Listing date (Tentative) | Sep 01, 2025 | Nov 14, 2025 |
| Anchor Lockin End date 1 | Sep 26, 2025 | Dec 11, 2025 |
| Anchor Lockin End date 2 | Nov 25, 2025 | Feb 09, 2026 |
Classic Electrodes IPO P/E ratio is 9.33, as compared to Curis Lifesciences IPO P/E ratio of 12.44.
| Classic Electrodes IPO | Curis Lifesciences IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)Curis Lifesciences Ltd.'s revenue increased by 38% and profit after tax (PAT) rose by 25% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 97.73 | 92.68 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 71.77 | 68.03 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 9.33 | 12.44 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹156.30 Cr. | ₹103.48 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 24.66 | 55.25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 17.68 | 27.83 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.23 | 0.96 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹9.32 | ₹10.29 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 21.95 | 37.62 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Classic Electrodes IPO Retail Individual Investors (RII) are offered 15,74,400 shares while in Curis Lifesciences IPO retail investors are offered 15,74,400 shares. Qualified Institutional Buyers (QIB) are offered 8,99,200 shares in Classic Electrodes IPO and 4,08,000 shares in Curis Lifesciences IPO.
| Classic Electrodes IPO | Curis Lifesciences IPO | |
|---|---|---|
| Anchor Investor Reservation | 13,44,000 shares | 6,09,000 shares |
| Market Maker Reservation | 2,78,400 shares | 1,08,000 shares |
| QIB | 8,99,200 shares | 4,08,000 shares |
| NII | 6,75,200 shares | 3,09,000 shares |
| RII | 15,74,400 shares | 7,16,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 44,92,800 shares | 20,42,000 shares |
Classic Electrodes IPO subscribed 179.97x in total, whereas Curis Lifesciences IPO subscribed 74.39x.
| Classic Electrodes IPO | Curis Lifesciences IPO | |
|---|---|---|
| QIB (times) | 84.88x | 96.17x |
| NII (times) | 356.75x | 115.46x |
| Big NII (times) | 421.54x | 142.74x |
| Small NII (times) | 227.62x | 60.38x |
| RII (times) | 158.44x | 44.28x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 179.97x | 74.39x |